Not applicableStudy completedNCT07155382What this trial is testingAllogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1Who this might be right forAcute Myeloid Leukemia (AML) Asan Medical Center 98
Testing effectiveness (Phase 2)Study completedNCT00548847What this trial is testingImmunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic TransplantationWho this might be right forLeukemia Emory University 15
Testing effectiveness (Phase 2)Ended earlyNCT05086315What this trial is testingFirst-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Who this might be right forAcute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more Sanofi 101
Testing effectiveness (Phase 2)Ended earlyNCT02877082What this trial is testingTacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant PatientsWho this might be right forAcute LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+9 more Emory University 5
Testing effectiveness (Phase 2)Study completedNCT02296242What this trial is testingPhase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromesWho this might be right forAcute Myelogenous LeukemiaMyelodysplastic Syndrome BioMed Valley Discoveries, Inc 53
Not applicableUnknownNCT00502983What this trial is testingMolecular Epidemiology of Acute Myelogenous LeukemiaWho this might be right forLeukemia M.D. Anderson Cancer Center 519
Testing effectiveness (Phase 2)Ended earlyNCT04849910What this trial is testingAllogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDSWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Vor Biopharma 67
Large-scale testing (Phase 3)Study completedNCT00703820What this trial is testingClofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia St. Jude Children's Research Hospital 324
Testing effectiveness (Phase 2)Study completedNCT00702403What this trial is testingNilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CMLWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more Fred Hutchinson Cancer Center 40
Early research (Phase 1)Study completedNCT01662505What this trial is testingVolasertib in Japanese Patients With Acute Myeloid Leukemia (AML)Who this might be right forLeukemia, Myeloid, Acute Boehringer Ingelheim 19
Early research (Phase 1)Study completedNCT01756118What this trial is testingA Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaLeukemia, Myelocytic, AcuteChronic Myelogenous Leukemia With Crisis of Blast Cells Goethe University 24
Testing effectiveness (Phase 2)Looking for participantsNCT04501120What this trial is testingStudy of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AMLWho this might be right forRelapsed/Refractory Acute Myeloid LeukaemiaMyeloid Malignancy Ascentage Pharma Group Inc. 682
Testing effectiveness (Phase 2)Looking for participantsNCT07025824What this trial is testingEvaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic TransplantationWho this might be right forAML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome) Technische Universität Dresden 220
Not applicableStudy completedNCT02867891What this trial is testingSorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML TrialWho this might be right forAcute Myeloid Leukemia Robert Zeiser 396
Large-scale testing (Phase 3)Looking for participantsNCT05939180What this trial is testingVA vs DA for Newly Diagnosed Hig-risk AMLWho this might be right forAcute Myeloid Leukemia The First Affiliated Hospital of Soochow University 116
Early research (Phase 1)Study completedNCT00098423What this trial is testingTanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic SyndromesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+23 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00346359What this trial is testingFludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more Fred Hutchinson Cancer Center 40
Large-scale testing (Phase 3)Looking for participantsNCT02416388What this trial is testingStudy to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRWho this might be right forAcute Myeloid Leukemia (AML) University Hospital, Angers 3,100
Early research (Phase 1)Study completedNCT01019161What this trial is testingAn Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)Who this might be right forAcute Myeloid Leukaemia AstraZeneca 5
Early research (Phase 1)WithdrawnNCT05823480What this trial is testingMagrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDSWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome City of Hope Medical Center